Simpler Grants.gov #FOR-DA-27-003

Forecasted Avant-Garde Award for High-Risk HIV and Substance Use Research

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is forecasting a grant opportunity for groundbreaking research in HIV and substance use or substance use disorders (SUDs). - Government Buyer: - National Institute on Drug Abuse (NIDA), National Institutes of Health - Program Details: - Avant-Garde Award Program for HIV and Substance Use Research - Seeks proposals for pioneering, high-risk, high-reward research - Open to exceptionally creative scientists, including early stage investigators - Focus on biomedical and behavioral research addressing HIV in the context of substance use - Funding Instrument: - Grant (no cost sharing or matching required) - Discretionary program under the health category - Notable Requirements: - No specific products, OEMs, or vendors involved (research grant only) - Funding opportunity number: FOR-DA-27-003 - No specified dollar amounts or number of awards - Period of Performance: - Estimated project start date is April 1, 2027 (duration not specified) - Place of Performance: - National Institute on Drug Abuse (NIDA)

Description

The National Institute on Drug Abuse (NIDA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for pioneering research in HIV and Substance use/substance use disorder (SUD) research. The Avant-Garde Award Program supports exceptionally creative scientists proposing high risk and high reward approaches to challenges in biomedical and behavioral research on HIV in the context of substance use and/or SUDs. This program includes support for early stage investigators. Applications are not currently being solicited; this notice allows potential applicants time to develop collaborations and projects.

View original listing